Prosecution Insights
Last updated: August 17, 2026

Examiner: SALVOZA, M FRANCO G

Tech Center 1600 • Art Units: 1600 1632 1648 1671 1672

This examiner grants 69% of resolved cases

Performance Statistics

68.7%
Allow Rate
+8.7% vs TC avg
658
Total Applications
+29.6%
Interview Lift
1153
Avg Prosecution Days
Based on 620 resolved cases, 2023–2026

Rejection Statute Breakdown

10.0%
§101 Eligibility
9.1%
§102 Novelty
28.0%
§103 Obviousness
29.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19217607 VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1) Non-Final OA University of Massachusetts
17925179 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION Non-Final OA EMORY UNIVERSITY
18268156 CORONAVIRUS RAPID DIAGNOSTICS Non-Final OA Massachusetts Institute of Technology
17655258 COMPOSITION FOR TREATING HEPATITIS B, AND METHOD FOR EVALUATING REPLICATION ACTIVITY OF HEPATITIS B VIRUS Final Rejection RIKEN
17917058 ASSAY TO DETECT VIRUS Non-Final OA CORNELL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month